Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MEMO1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | PERM1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SYK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SF3B3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | PPP6C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SECISBP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C11orf84 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ATP6V1E1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | POC1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZNF200 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |